Translate Bio Announces FDA Clearance to Proceed with a Single-ascending Dose (SAD) Phase 1/2 Clinical Trial for Ornithine Transcarbamylase (OTC) Deficiency

June 26, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search